DuPont

Accelerated Enrollment Solutions (AES) helps biopharmaceutical companies overcome patient recruitment and research site challenges to deliver greater speed, certainty, and control to clinical trial delivery.

Through the combination of a powerful patient recruiting solution and more than 160 owned and partnered clinical research sites throughout the world, AES provides a single global source for clinical trial sites and patients that delivers centralized control, consistent operations and quality worldwide, and more patients from fewer sites in less time.

AES is a business of PPD, a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services.

For more information, visit www.globalAES.com.

Our vision is to conduct clinical trials better and more cost effectively than anyone else. We accomplish this by working with our clients to not only deliver the clinical trial effectively, on time and within budget, but also by leveraging our in-depth expertise to ensure the clinical trial is properly designed.

We believe there is increasing need for innovation, creativity and scientific expertise in clinical research, characteristics often synonymous with small Biopharma and hence, though we are proud to have a number of the world’s largest pharmaceutical companies as our clients, greater than 80% of our client portfolio is small Biopharma.

ACLIRES has performed trials for an international array of biotech companies as well as for some of the largest global pharmaceutical companies. With our broad access to patients and expertise, our aim is to rapidly initiate our client’s studies, even when a very special patient population is required.

Our services include:
- Early Phase Studies
- Late Phase Studies
- Recruitment
- Regulatory Affairs
- Monitoring
- Site Selection
- Scientific Services/Medical Writing
- Consulting
- Quality Management

For more than 35 years, BBK Worldwide (BBK) has been instrumental in the development and evolution of the patient recruitment industry. With a commitment to innovate, the company pushes the industry forward with the development of game-changing tools and technologies that enroll and engage patients in clinical trials. BBK was founded by Joan F. Bachenheimer and Bonnie A. Brescia, inspired by a shared commitment to advocate for patients and patient-centric care.

BBK’s suite of solutions address the needs of today’s clinical trial sponsors, with a focus on products and services that educate consumers, engage participants, unburden sites, and support sponsors. Committed to transforming the patient experience, the company’s end-to-end solutions support the entire clinical trial journey.

Cohortias is the SCIENCE CRO for Latin America, merging the high efficiency standards required for CLINICAL RESEARCH with tight and unbiased scientific rigor characteristic of academia. Through our extensive academic liaisons in Latin America we have built a broad and highly reputable network of sites which can access patients in a timely manner and operate with the highest quality standards. This ensures an easier entrance for products into the market.

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research for Latin America.

Cohortias offers specialized staff to perform all aspects of site management and clinical research monitoring throughout Latin America, and we can scale to facilitate all the required clinical site management services.

Our academic network offers access to the leading investigators in their respective therapeutic areas in Latin America, and peer-to-peer management to guarantee the highest recruitment and retention.

We provide our CRO Services with offices in:

- Mexico
- Brazil
- Colombia
- Argentina

We believe in opening the opportunity of Clinical trials for the patient population in Latin America, and thus leveraging the transformation of healthcare in the region, through better access for care and better care for each one.

Cromos Pharma is an international CRO with expertise in delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas.

Cromos Pharma offers fully integrated CRO services including regulatory consulting and compliance, project management; monitoring; medical writing; data management and biostatistics; drug and device registration services; logistics and warehousing; post-marketing services and independent audits. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management.

Cromos Pharma's "No Patients - No Payments"​ initiative allows the sponsors to pay for performance and is our guarantee that the study timelines will be met.

Established in Moscow in 2004, Cromos Pharma has strong regional presences in Central and Eastern Europe, Russia and Post-Soviet Bloc countries. Its European HQ is situated in Dublin, Ireland and its US base is in Portland, Oregon.